Pancreatic Cancer Research

ResearcherComplejo Hospitalario de OurenseNo recent work listed

Mónica Jorge Fernández

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5108713408. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcino… First author DOI 10.1007/s00280-020-04214-w↗
  2. Prognostic and predictive markers of response to treatment in patients with locally advanced unresectable and metastatic pancreatic adenocarcinoma treated with… Last author DOI 10.4103/0973-1482.181181↗
  3. Phase II trial of erlotinib plus capecitabine as first-line treatment for metastatic pancreatic cancer (XELTA study). Co-author PMID 23393373↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ana Fernández Montés · 2 shared papers, 2017–2021 · strength 0.18
  2. Guillermo López-Vivanco · 1 shared paper, 2021 · strength 0.11
  3. Jaime Feliú · 1 shared paper, 2021 · strength 0.11
  4. Ana María López Muñoz · 1 shared paper, 2021 · strength 0.11
  5. Teresa Mercade Macarulla · 1 shared paper, 2021 · strength 0.11
  6. Sonia Candamio Folgar · 1 shared paper, 2013 · strength 0.03
  7. Rafael López‐López · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.